Comparing short‐term outcome after implantation of the HeartWare® HVAD® and the Abbott® HeartMate 3®
Abstract Aims Centrifugal continuous flow pumps are currently the state of the art in left ventricular assist device therapy. This study was conducted to compare the results after implantation of the HVAD® and the HeartMate 3®. Methods and results We retrospectively analysed preoperative and post‐op...
Saved in:
Main Authors: | Rene Schramm, Armin Zittermann, Michiel Morshuis, Michael Schoenbrodt, Ellen vonRoessing, Vera vonDossow, Andreas Koster, Henrik Fox, Kavous Hakim‐Meibodi, Jan F. Gummert |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-06-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.12649 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-term outcomes after percutaneous withdrawal of HeartWare left ventricular assist device (HVAD) support: A 10-year update
by: Chokanan Thaitirarot, et al.
Published: (2025-02-01) -
HeartMate 3 upgrade and aortic root replacement for severe aortic insufficiency and ventricular fibrillation
by: Katlin T. Schmitz, MD, et al.
Published: (2025-05-01) -
Berenice Abbott (1898-1991), photographies
by: Juliette Mélia
Published: (2012-05-01) -
Longest Known Survivor With HeartMate II Continuous‐Flow Left Ventricular Assist System—A Case Report of the 16‐Year Success Story
by: Yamane Chawa, et al.
Published: (2025-01-01) -
Tunrayo Ayinke Ayinla: The Unsung Burnish Black Glaze Wares Ceramist of Ilorin
by: Toyin E. Akinde
Published: (2023-01-01)